GLP-1 Drugs Associated with 30% Lower Parkinson's Disease Risk in Observational Studies from Large Meta-Analysis
The expanding use of GLP-1 receptor agonists beyond diabetes management may be reshaping neurological disease prevention in ways researchers are only…